Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
about
Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitusOral Hypoglycemic Agents in pregnancy: An UpdatePost-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarboseReduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapyCoordinate regulation of glucose transporter function, number, and gene expression by insulin and sulfonylureas in L6 rat skeletal muscle cellsType 2 diabetes therapy. A pathophysiologically based approach.Hepatic glucose production: therapeutic target in type 2 diabetes?When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus.The use of oral antidiabetic medications in gestational diabetes mellitus.The sulphonylurea drug, glimepiride, stimulates release of glycosylphosphatidylinositol-anchored plasma-membrane proteins from 3T3 adipocytes.Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetesDrugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism.Pregnancy and diabetes scenario around the world: Africa.Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.Non insulin-dependent diabetes mellitus (type 2) secondary failure. Metformin-glibenclamide treatment.Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.
P2860
Q24234519-3AFFBF05-7506-4DD1-8483-11FB2678B42BQ26851879-417CD910-407E-4A46-B051-92A77F74E2D2Q33756059-C565FA0B-906F-403D-B2CB-B20519CDFA15Q34182003-52962248-3B3D-4CB8-B518-EE2645102F2AQ34576372-FA34EE8D-B0E5-4D24-8121-4468408254BEQ34576374-5C47699F-163E-45A3-B820-67592C8A94EAQ34722593-F68D321F-E1BF-4C17-93A6-91F46C8637AAQ34957940-D837A417-40D4-4802-BE47-E747023C81FDQ34994665-3C4AAA70-3D8D-4DBC-A250-4BC9F9349275Q36694998-F2886D05-8956-439D-9B0B-DEE941BD5A2EQ37240102-CB967F94-2A36-426E-86EA-E8F44A8BEBF7Q40623938-9651191B-0EE7-4A73-B5B8-B3DE4BAE933FQ44182401-F391D68D-F431-4EE1-BDAB-CB3B00D0AD9BQ46302044-476095C7-B918-4BE0-BDAE-6FD2DB5DF46EQ51538046-F55C732B-A014-4E74-A669-F84FDFC5D59BQ51607493-B5FFF37F-9FAD-4142-A126-B5023AA90EE0
P2860
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
@en
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
@nl
type
label
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
@en
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
@nl
prefLabel
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
@en
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
@nl
P2093
P356
P1433
P1476
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
@en
P2093
Bevilacqua S
DeFronzo RA
Ferrannini E
Simonson DC
P304
P356
10.2337/DIAB.33.9.838
P407
P577
1984-09-01T00:00:00Z